A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal disease

Abstract excerpt

Although meningococcal disease caused by serogroup B remains an important public health concern, a licensed vaccine providing broad protection against this pathogen is not yet available. Advances in genomics have paved the way for the discovery of new vaccine candidates for inclusion into a multicomponent serogroup B vaccine. In this article, we will review recent advances in the development of these vaccines,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Bacterial Infections and Vaccines
• Share to Pneumocystis jirovecii pneumonia detection and treatment
• Share to Pneumonia and Respiratory Infections